EBS vs W · rev $1.04B vs rev $11.85B
Emergent Biosolutions Inc (EBS) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
EBS currently screens at market cap $416.4M. W currently screens at market cap $10.77B.
Not investment advice. Open the EBS and W stock pages for the full models.
Not investment advice.